Categories:
Tags:

Making Pharmaceuticals Exhibition & Conference

From Research to Finished Product Making Pharmaceuticals 2020 will bring together 200 exhibiting companies and the key decision makers and innovators from across the Pharmaceuticals sector. Meet, network and do business with hundreds of…

Cannabinoids in pharmaceutical development

The development of cannabinoids in the pharmaceutical industry has exploded over the past few years. With the gradual liberation of regulations worldwide that govern cannabis and its pharmaceutical derivatives for medicinal use, this week…

Poster presentation Gattefossé

See the presentation of Sophie Hughes from Gattefossé at CPhI Worldwide where she talked through a poster presentation on the formulating of cannabinoids with lipid excipients. To find out more about this and Gattefossé´s whole portfolio of…

Liquid filling of hard gelatine capsules

Liquid filling of hard gelatine capsules is an interesting approach to handle oily substances such as plant extracts incl. CBD in a better way. IN-CAP has become very popular all over the World among R&D Laboratories, Pharmacies,…

Lipid Excipients for Cannabinoid Drug Products

With an enhanced understanding of the medicinal benefits and looming ease of regulations around the globe, there is an expressed need for science based, adequately dosed, and age appropriate cannabinoid medicines. The benefits of…

Maisine® CC as a lipid excipient

Maisine® CC is a pharmaceutical oily vehicle used to enhance the solubility and oral bioavailability of lipophilic drugs. Maisine® CC is derived from corn oil with a unique and highly reproducible composition in linoleic mono-di and…

Lipid Excipients for Cannabinoid Drug Products

The introduction of the cannabis plant into Western medicine dates to the 19th century when the plant was first used as an additive to patented medicines. The development of cannabis based therapies in the modern sense however came to a…